EX-1 2 Exhibit.txt EXHIBIT January10, 2023 Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Ladies and Gentlemen: We have read the statements made by Musclepharm Corporation included under Item 4.01 of its Current Report on Form 8-K dated January4, 2023, to be filed with the Securities and Exchange Commission. We agree with the statements concerning our Firm contained therein. Sincerely, Moss Adams LLP